# FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer

> **NCT06877949** · NA · RECRUITING · sponsor: **Odense University Hospital** · enrollment: 420 (estimated)

## Conditions studied

- Metastatic Breast Cancer
- Response Monitoring

## Interventions

- **DIAGNOSTIC_TEST:** FDG-PET/CT
- **DIAGNOSTIC_TEST:** CE-CT

## Key facts

- **NCT ID:** NCT06877949
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-02
- **Primary completion:** 2029-04
- **Final completion:** 2029-04
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06877949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06877949, "FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06877949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*